SCHEMBL3853383

SCHEMBL3853383

Brc1cccc(CN2CCNCC2)n1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 8/20 0.65
FAAH O00519 1/20 0.51
SIGMAR1 Q99720 1/20 0.47
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.41
KDM5C P41229 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
DRD2 P14416 1/20 0.40
DRD3 P35462 1/20 0.40
MEN1 O00255 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
ADRA2C P18825 1/20 0.40
CCR2 P41597 1/20 0.40
CXCL12 P48061 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29604268 0.86 CXCR4 (0.78) CXCR4SIGMAR1LMNAKDM5CKDM4C
Hydrochloric Acid SCHEMBL5570623 0.86 CXCR4 (0.78) CXCR4SIGMAR1LMNAKDM5CKDM4C
Bromide SCHEMBL29604778 0.86 CXCR4 (0.78) CXCR4SIGMAR1LMNAKDM5CKDM4C
SCHEMBL839038 0.83 FAAH (0.53) CXCR4FAAHALDH1A1DRD2DRD3
SCHEMBL28184599 0.81 CXCR4 (0.58) CXCR4FAAHDRD2DRD3MEN1
SCHEMBL1089502 0.80 CXCR4 (0.65) CXCR4SIGMAR1LMNAKDM5CKDM4C
SCHEMBL465778 0.80 CXCR4 (0.77) CXCR4FAAHALDH1A1MEN1KMT2A
SCHEMBL17996820 0.80 CXCR4 (0.65) CXCR4SIGMAR1LMNAKDM5CKDM4C
SCHEMBL465722 0.80 CXCR4 (0.65) CXCR4SIGMAR1LMNAKDM5CKDM4C
SCHEMBL20831292 0.80 CXCR4 (0.65) CXCR4SIGMAR1LMNAKDM5CKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102388043-A Histamine h3 inverse agonists and antagonists and methods of use thereof SEPRACOR INC 2012-03-21 CN disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed